Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two... see more

Recent & Breaking News (NDAQ:BMRA)

Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis

GlobeNewswire 4 days ago

Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements

GlobeNewswire November 7, 2024

Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

GlobeNewswire October 30, 2024

Biomerica Reports First Quarter Fiscal 2025 Financial Results

GlobeNewswire October 16, 2024

The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer

GlobeNewswire September 4, 2024

Biomerica Reports Fiscal 2024 Year End Results

GlobeNewswire August 29, 2024

Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers

GlobeNewswire July 1, 2024

Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024

GlobeNewswire May 13, 2024

Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

GlobeNewswire April 29, 2024

Biomerica provides update on inFoods® IBS expansion

GlobeNewswire April 15, 2024

Biomerica Reports Third Quarter 2024 Financial Results

GlobeNewswire April 12, 2024

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

GlobeNewswire March 28, 2024

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

GlobeNewswire February 21, 2024

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

GlobeNewswire January 23, 2024

Biomerica Reports Second Quarter 2024 Financial Results

GlobeNewswire January 16, 2024

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect(TM) ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

GlobeNewswire December 18, 2023

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

GlobeNewswire November 10, 2023

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

GlobeNewswire November 8, 2023

REPEAT - Biomerica Reports First Quarter 2024 Financial Results

GlobeNewswire October 13, 2023

Biomerica Reports First Quarter 2024 Financial Results

GlobeNewswire October 13, 2023